Karolina Valente
Vorstandsvorsitzender bei Voxcell Bioinnovation, Inc.
Ursprung des Netzwerks ersten Grades von Karolina Valente
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Voxcell Bioinnovation, Inc.
 Voxcell Bioinnovation, Inc. Industrial MachineryProducer Manufacturing Voxcell Bioinnovation, Inc. is a Canadian company that creates solutions for the drug development industry and Oncology research. The company is based in Victoria, Canada. The company offers a range of products including Novel Bioinks, Truly Biomimetic Tissue Models for in vitro drug testing, and a unique super high resolution 3D Bioprinter. The company was founded by Karolina Valente and she has been the CEO since incorporation.
2
| Holding Company | Industrial Machinery | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Karolina Valente
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| University of British Columbia | College/University | Undergraduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin |
Statistik
International
| Kanada | 3 |
| Vereinigte Staaten | 2 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert Levak | 4 |
| Nina Vellani | 1 |
- Börse
- Insiders
- Karolina Valente
- Unternehmensverbindungen
